Table 2.
Time | Access | |||||||
Module/Section | Mean (SD)a Time in Seconds Spent in Module/ Section |
Range | Total Number of Pages in Module/ Section |
Mean Number (SD)b of Pages Viewed |
Percent of Available Pages Viewed Among Men in Each Group | |||
Low Access (n = 37) |
Intermediate Access (n = 18) | High Access (n = 27) |
||||||
PROSDEX site | 1191 (914) | 75-3672 | 60 | 32 (21) | 19 | 60 | 94 | |
The PSA Test | 412 (329) | 0-1385 | 19 | 11 (6) | 37 | 58 | 91 | |
Introduction | 8 (19) | 0-99 | 1 | 0.5 (0.5) | 24 | 28 | 37 | |
What is the PSA test? | 91 (66) | 0-310 | 3 | 2 (1) | 67 | 85 | 94 | |
PSA test results | 132 (129) | 0-772 | 5 | 3 (2) | 45 | 68 | 92 | |
PSA controversies | 103 (118) | 0-420 | 6 | 3 (2) | 28 | 44 | 93 | |
What is screening? | 76 (87) | 0-327 | 4 | 2 (2) | 22 | 56 | 97 | |
It’s Your Choice | 218 (263) | 0-996 | 19 | 9 (8) | 5 | 51 | 97 | |
Introduction | 13 (15) | 0-77 | 1 | 1 (0.5) | 54 | 83 | 93 | |
Making the best decisions | 18 (49) | 0 -394 | 2 | 1 (1) | 4 | 58 | 94 | |
Knowing enough to choose | 65 (85) | 0-302 | 5 | 2 (2) | 1 | 70 | 99 | |
Shared decision making |
49 (70) | 0-285 | 4 | 2 (2) | 3 | 42 | 98 | |
Choices about the PSA test | 44 (70) | 0-341 | 4 | 2 (2) | 2 | 32 | 99 | |
Screening in other countries | 29 (42) | 0-212 | 3 | 1 (1) | 5 | 39 | 94 | |
Prostate Cancer | 428 (449) | 0-1824 | 22 | 12 (9) | 15 | 70 | 94 | |
Introduction | 15 (14) | 0-63 | 1 | 1 (0.5) | 43 | 100 | 96 | |
The prostate | 70 (68) | 0-231 | 3 | 2 (1) | 20 | 70 | 95 | |
Understanding the risks | 60 (82) | 0-503 | 4 | 2 (2) | 12 | 76 | 100 | |
Detecting prostate cancer | 114 (169) | 0-733 | 5 | 3 (2) | 17 | 63 | 91 | |
Treating prostate cancer | 115 (180) | 0-883 | 5 | 2 (2) | 10 | 68 | 90 | |
Early treatment | 50 (59) | 0-228 | 4 | 2 (2) | 12 | 65 | 94 |
a based on 74 participants (8 outliers excluded)
b based on 82 participants (8 outliers did not sufficiently distort usage data)